Diabetic Health Inc.
Streamlining glucose monitoring and insulin administration
Diabetic Health, Inc. (formerly Clinical Sensors, Inc.) develops coatings that mitigate the foreign body response (FBR) to continuous glucose monitoring sensors (CGM) and insulin infusion sets. These devices are used by millions of diabetes patients to control their blood glucose and reduce the likelihood of severe complications of diabetes. Because these devices act underneath the skin, they trigger the FBR, which limits long-term accuracy, performance and patient convenience.
Our core products are nanoparticles that store and release nitric oxide, an endogenous, anti-inflammatory metabolite. These nanoparticles are dispersed in medical grade polymers and deposited onto device surfaces to form thin films. The coated devices are then inserted into the patient where they release minute amounts of nitric oxide, protecting the device from the FBR and prolonging its functional lifetime.
Nitric oxide acts locally, so the device-protective effect is only delivered where and when it is needed.